Ole H Petersen Selected Research

Ole H Petersen Research Topics

Disease

38	Pancreatitis 01/2023 - 01/2003
19	Necrosis 10/2021 - 02/2006
6	Inflammation (Inflammations) 01/2022 - 08/2013
6	Acute Disease 03/2016 - 11/2006
4	Neoplasms (Cancer) 11/2019 - 07/2009
2	Gallstones (Gallstone) 01/2019 - 01/2018
2	Alcoholism (Alcohol Abuse) 01/2018 - 11/2006
1	Alcoholic Pancreatitis 01/2022
1	COVID-19 01/2021
1	Hypertriglyceridemia 04/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018
1	Bile Reflux 11/2016
1	Chronic Pancreatitis 03/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2014

Drug/Important Bio-Agent (IBA)

14	CalciumIBA 01/2023 - 01/2003
10	EnzymesIBA 01/2022 - 01/2003
9	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 03/2006
8	Bile Acids and Salts (Bile Acids)IBA 01/2018 - 06/2004
7	Adenosine Triphosphate (ATP)IBA 10/2021 - 02/2006
6	EstersIBA 08/2014 - 03/2006
5	BradykininIBA 01/2021 - 01/2016
5	Peptide Hydrolases (Proteases)FDA Link 01/2014 - 11/2006
4	Ethanol (Ethyl Alcohol)IBA 01/2022 - 03/2006
4	taurolithocholic acid 3-sulfate (TLC-S)IBA 01/2018 - 12/2006
3	TrypsinIBA 01/2018 - 06/2009
3	Peptides (Polypeptides)IBA 01/2018 - 12/2009
3	Enzyme Precursors (Zymogens)IBA 01/2016 - 01/2003
3	CytokinesIBA 01/2016 - 01/2007
3	NAD (NADH)IBA 08/2014 - 12/2006
3	TrypsinogenIBA 04/2011 - 03/2007
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2017
2	Asparaginase (Elspar)FDA Link 01/2018 - 01/2016
2	Caffeine (No Doz)FDA LinkGeneric 01/2017 - 02/2006
2	Cholecystokinin (Pancreozymin)IBA 01/2016 - 03/2007
2	Calcium Release Activated Calcium ChannelsIBA 01/2016 - 08/2013
2	Oxidoreductases (Dehydrogenase)IBA 06/2011 - 12/2006
1	IonsIBA 10/2021
1	venetoclaxIBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2018
1	Taurolithocholic AcidIBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2017
1	GossypolIBA 01/2017
1	XanthinesIBA 01/2017
1	CholatesIBA 11/2016
1	SodiumIBA 11/2016
1	Taurocholic Acid (Sodium Taurocholate)IBA 11/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2016
1	Free RadicalsIBA 08/2016
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2016
1	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 01/2016
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2016
1	Calcium Channels (Calcium Channel)IBA 01/2016
1	ElementsIBA 01/2016
1	Choline (Choline Chloride)IBA 01/2016
1	PAR-2 ReceptorIBA 01/2016
1	EthionineIBA 01/2016
1	Inositol (Myoinositol)IBA 01/2016
1	Mitochondrial Permeability Transition PoreIBA 01/2016
1	3-benzyl-6-chloro-2-pyroneIBA 08/2014
1	4-methylpiperazine-2,6-dioneIBA 08/2014
1	fatty acyl ethyl ester synthaseIBA 08/2014
1	Carboxylesterase (Hydrolase S)IBA 08/2014
1	palmitoleic acidIBA 08/2013
1	caloxin 3A1IBA 07/2012
1	Quinine (Quinson)FDA Link 06/2011
1	NADP (NADPH)IBA 06/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2011
1	AntioxidantsIBA 06/2011
1	Acetylcysteine (Siran)FDA LinkGeneric 06/2011
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2011
1	SecretagoguesIBA 05/2010
1	Sincalide FDA Link 12/2009
1	cholecystokinin 58IBA 12/2009
1	Vitamin K 3 (Menadione)FDA Link 07/2009
1	AcidsIBA 06/2009
1	Bicarbonates (Hydrogen Carbonate)IBA 05/2008
1	quinone (benzoquinone)IBA 12/2006
1	CholestanolsIBA 02/2006
1	Coffee FDA Link 02/2006
1	NF-kappa B (NF-kB)IBA 01/2003

Therapy/Procedure

4	Therapeutics 11/2019 - 01/2007
1	Endoscopic Sphincterotomy 01/2019
1	Cholecystectomy 01/2019
1	Drug Therapy (Chemotherapy) 01/2016